Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$261M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$241M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$234M |
| 4 |
Keurig Dr Pepper
KDP
|
+$173M |
| 5 |
FedEx
FDX
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.21% |
| 2 | Technology | 11.19% |
| 3 | Healthcare | 7.18% |
| 4 | Consumer Discretionary | 7.09% |
| 5 | Financials | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Larimar Therapeutics
LRMR
$421M
| $789K | ﹤0.01% |
36,862
-7,024
| -16% | -$141K |
|
3827
Interparfums
IPAR
$3.76B
| $787K | ﹤0.01% |
13,018
-4,562
| -26% | -$230K |
|
3828
Neuronetics
STIM
$226M
| $786K | ﹤0.01% |
+70,746
| New | +$532K |
|
3829
Safety Insurance
SAFT
$1.52B
| $785K | ﹤0.01% |
10,081
-34,309
| -77% | -$2.52M |
|
3830
Nuveen Floating Rate Income Fund
JFR
$1.22B
| $784K | ﹤0.01% |
+89,715
| New | +$756K |
|
3831
Cohen & Steers Closed End Opportunity Fund
FOF
$376M
| $783K | ﹤0.01% |
+63,031
| New | +$720K |
|
|
HPI
3832
John Hancock Preferred Income Fund
HPI
$425M
| $783K | ﹤0.01% |
+39,775
| New | +$760K |
|
3833
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42.2B
| $783K | ﹤0.01% |
23,187
+14,719
| +174% | +$464K |
|
3834
CVB Financial
CVBF
$3.92B
| $782K | ﹤0.01% |
40,128
-78,903
| -66% | -$1.49M |
|
3835
Nkarta
NKTX
$197M
| $782K | ﹤0.01% |
+12,722
| New | +$528K |
|
|
NBTX
3836
Nanobiotix
NBTX
$2.29B
| $780K | ﹤0.01% |
+47,261
| New | +$814K |
|
|
K
3837
CALL
DELISTED
Kellanova
K
| $778K | ﹤0.01% |
+13,313
| New | +$800K |
|
|
MILEW
3838
CALL
DELISTED
Metromile, Inc. Warrant
MILEW
| $778K | ﹤0.01% |
+50,000
| New | +$151K |
|
3839
Intercorp Financial Services
IFS
$6B
| $775K | ﹤0.01% |
23,964
-6,080
| -20% | -$158K |
|
|
HCCI
3840
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $774K | ﹤0.01% |
+36,754
| New | +$681K |
|
3841
Bread Financial
BFH
$4.15B
| $773K | ﹤0.01% |
13,070
-81,113
| -86% | -$4.08M |
|
|
HBI
3842
DELISTED
Hanesbrands
HBI
| $773K | ﹤0.01% |
53,014
-522,684
| -91% | -$7.89M |
|
3843
Astrana Health
ASTH
$1.91B
| $773K | ﹤0.01% |
42,334
-29,877
| -41% | -$537K |
|
3844
iShares Semiconductor ETF
SOXX
$42.8B
| $771K | ﹤0.01% |
6,099
-12,024
| -66% | -$1.38M |
|
3845
CALL
Krystal Biotech
KRYS
$10.6B
| $768K | ﹤0.01% |
12,800
+2,800
| +28% | +$140K |
|
3846
iShares Global REIT ETF
REET
$5.03B
| $768K | ﹤0.01% |
+32,076
| New | +$723K |
|
|
VTRU
3847
DELISTED
Vitru Limited Common Shares
VTRU
| $768K | ﹤0.01% |
52,571
-24,091
| -31% | -$333K |
|
|
CLDB
3848
DELISTED
CORTLAND BNCP CRTLD OHIO
CLDB
| $767K | ﹤0.01% |
41,189
-4,510
| -10% | -$72.3K |
|
|
KIO
3849
KKR Income Opportunities Fund
KIO
$452M
| $766K | ﹤0.01% |
+53,071
| New | +$739K |
|
|
ITI
3850
DELISTED
Iteris, Inc.
ITI
| $766K | ﹤0.01% |
135,585
-41,982
| -24% | -$200K |
|
Similar funds
Israel Englander's Q4 2020 Portfolio in Review
As of Q4 2020, Israel Englander held 5,904 positions worth $138B, up 71% from $81.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $25B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Israel Englander's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Israel Englander's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Israel Englander fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $261M.
- Israel Englander's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Israel Englander opened 1,518 new positions and closed 754 in Q4 2020.
- Israel Englander's portfolio value rose 71% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.